Virtus Health Ltd
ASX:VRT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of VRT.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
|
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
|
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
|
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
|
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
|
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
|
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
|
| US |
|
Universal Health Services Inc
NYSE:UHS
|
|
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Heightened competition from both established fertility clinics and emerging telehealth fertility solutions may pressure Virtus Health’s market share and erode pricing power, especially in core Australian markets.
Regulatory changes limiting IVF subsidies or altering legal frameworks around fertility treatments could significantly raise operational costs or reduce patient demand, undermining margins.
Any reputational damage—whether from negative outcomes, compliance issues, or perceived ethical breaches—could deter patients from choosing Virtus Health’s services, weakening its brand advantage.
Strong demographic tailwinds, such as rising maternal age and greater social acceptance of IVF, could sustain long-term growth in fertility treatments and solidify Virtus Health’s position as a market leader.
Ongoing investments in cutting-edge reproductive technologies and data-driven fertility treatments may strengthen Virtus Health’s clinical success rates and allow it to command premium pricing over less sophisticated competitors.
Geographic expansion, including selective acquisitions of IVF clinics and strategic partnerships outside Australia, diversifies Virtus Health’s revenue base and positions the company to capture growth in underserved international markets.
Revenue & Expenses Breakdown
Virtus Health Ltd
Balance Sheet Decomposition
Virtus Health Ltd
| Current Assets | 38.6m |
| Cash & Short-Term Investments | 18.5m |
| Receivables | 12.1m |
| Other Current Assets | 8m |
| Non-Current Assets | 550.9m |
| Long-Term Investments | 1.8m |
| PP&E | 110.6m |
| Intangibles | 427.2m |
| Other Non-Current Assets | 11.2m |
| Current Liabilities | 71.1m |
| Accounts Payable | 34.8m |
| Other Current Liabilities | 36.2m |
| Non-Current Liabilities | 179.8m |
| Long-Term Debt | 169.3m |
| Other Non-Current Liabilities | 10.4m |
Free Cash Flow Analysis
Virtus Health Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Virtus Health Ltd
|
Revenue
|
326.3m
AUD
|
|
Cost of Revenue
|
-92.3m
AUD
|
|
Gross Profit
|
234m
AUD
|
|
Operating Expenses
|
-187.8m
AUD
|
|
Operating Income
|
46.2m
AUD
|
|
Other Expenses
|
-17.8m
AUD
|
|
Net Income
|
28.3m
AUD
|
VRT Profitability Score
Profitability Due Diligence
Virtus Health Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Virtus Health Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
VRT Solvency Score
Solvency Due Diligence
Virtus Health Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Score
Virtus Health Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VRT Price Targets Summary
Virtus Health Ltd
Dividends
Current shareholder yield for
VRT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?